Biomarkers for Transient Ischemic Attack: A Brief Perspective of Current Reports and Future Horizons
Open Access
- 17 February 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 1046
Abstract
Cerebrovascular disease is the leading cause of long-term disability in the world and the third-leading cause of death in the United States. The early diagnosis of transient ischemic attack (TIA) is of great importance for reducing the mortality and morbidity of cerebrovascular diseases. Patients with TIA have a high risk of early subsequent ischemic stroke and the development of permanent nervous system lesions. The diagnosis of TIA remains a clinical diagnosis that highly relies on the patient’s medical history assessment. There is a growing list of biomarkers associated with different components of the ischemic cascade in the brain. In this review, we take a closer look at the biomarkers of TIA and their validity with a focus on the more clinically important ones using recent evidence of their reliability for practical usage.Keywords
This publication has 144 references indexed in Scilit:
- Prognostic Value of Inflammatory Mediators in 1-Year Outcome of Acute Ischemic Stroke with Middle Cerebral Artery StenosisMediators of Inflammation, 2013
- Ischemic stroke is associated with the ABO locus: The EuroCLOT studyAnnals of Neurology, 2012
- Ischemic Transient Neurological Events Identified by Immune Response to Cerebral IschemiaStroke, 2012
- The Many Faces of TauNeuron, 2011
- Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association studyThe Lancet Neurology, 2010
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- von Willebrand factor–cleaving protease ADAMTS13 reduces ischemic brain injury in experimental strokeBlood, 2009
- The Promise and Potential Pitfalls of Serum Biomarkers for Ischemic Stroke and Transient Ischemic AttackThe Neurologist, 2008
- Copeptin: clinical use of a new biomarkerTrends in Endocrinology & Metabolism, 2008
- Molecular markers of early Parkinson's disease based on gene expression in bloodProceedings of the National Academy of Sciences, 2007